JPRN-UMIN000004968招募中未知
A pharmacogenomics study for adverse effects and clinical outcome to S-1 in gastric cancer patients - Pharmacogenomics study for individual response to S-1
Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka0 个研究点目标入组 100 人开始时间: 2011年2月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Known prior severe hypersensitivity to clinical trial medicines 2) Patients who do not have enough whole body state to the antineoplastic agents treatment 3) Pregnant, breastfeeding or expecting woman 4) Other clinical difficulties in this study
研究者
相似试验
尚未招募
不适用
A study to identify clinical and inborn risk factors for development of vision impairment in patients on Ethambuol, an antituberculosis drugCTRI/2022/08/045044Duke NUS Program Grant Award
已完成
不适用
Genome analysis on drug adverse reactioMalignant diseasesJPRN-UMIN000015784Department of Medical Oncology Graduate School of Medicine, Chiba University55
招募中
不适用
Pharmacogenetic analysis to investigate the association between efficacy and neurotoxicity of oxaliplatin and single nucleotide polymorphismsColorectal cancerJPRN-UMIN000002490Kyoto University Hospital133
已完成
不适用
adverse drug reactions and quality of life with anti-hiv treatmentCTRI/2019/02/017398Dr Ruchika Irene Dillu100
已完成
不适用
Adverse effects of COVID VACCINESCTRI/2021/06/034208YENEPOYA MEDICAL COLLEGE100